Communicators inside the White House would do well to stop maligning public health experts, for the sake of the country and their own credibility, says a former HHS press officer.
HHS to receive COVID-19 patient data; Radiation may help speed recovery from coronavirus-related pneumonia; Podcast: WebMD’s Dr. John Whyte.
A previous judge ruled that HHS did not have the authority to issue the rule.
The government has relaxed telehealth rules as most people stay home to help flatten the curve, but patients still face barriers for virtual visits.
The FDA released new spots for its ongoing youth vaping prevention campaign, The Real Cost.
The appeals court questioned HHS’ authority and whether the list price would only confuse consumers.
The White House’s strategy calls for moving expensive treatments from under Medicare Part B to Medicare Part D.
For one of President Trump’s proposals for lowering the cost of drugs, the path to implementation could be long.
Sanofi to buy Bioverativ for $11.6 billion; Celgene to acquire Juno for $9 billion; Teva to lay off more than 200 in Philadelphia
Senate committee votes in favor of Azar as new HHS head; FDA and DoD launch breakthrough designation program; Walmart offers free opioid disposal solution
